Clinical and economic comparison of an individualised immunoglobulin protocol vs. standard dosing for chronic inflammatory demyelinating polyneuropathy-Reference-Cited by-同舟云学术

Clinical and economic comparison of an individualised immunoglobulin protocol vs. standard dosing for chronic inflammatory demyelinating polyneuropathy

Published:2018-12-17 Issue:2 Volume:266 Page:461-467
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Rajabally Yusuf A.,Afzal Saadia

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/article/10.1007/s00415-018-9157-4/fulltext.html

Reference22 articles.

1. Rajabally YA, Simpson BS, Beri S, Bankart J, Gosalakkal JA (2009) Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population. Muscle Nerve 39:432–438

2. Mahdi-Rogers M, Hughes RA (2014) Epidemiology of chronic inflammatory neuropathies in southeast England. Eur J Neurol 21:28–33

3. Rajabally YA, Seow H, Wilson P (2006) Dose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 11:325–329

4. Mahdi-Rogers M, McCrone P, Hughes RA (2014) Economic costs and quality of life in chronic inflammatory neuropathies in southeast England. Eur J Neurol 21:34–39

5. Blackhouse G, Gaebel K, Xie F, Campbell K, Assasi N, Tarride JE et al (2010) Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in Canada. Cost Eff Resour Alloc 8:14

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal Weight-Based Dosing of Intravenous Immunoglobulin (IVIG) among Overweight and Obese Patients;Current Drug Therapy;2024-06

2. Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Current Therapeutic Approaches and Future Outlooks;ImmunoTargets and Therapy;2024-02

3. Association of the neonatal Fc receptor promoter variable number of tandem repeat polymorphism with immunoglobulin response in patients with chronic inflammatory demyelinating polyneuropathy;European Journal of Neurology;2024-01-11

4. Efficacy of hematopoietic stem cell transplantation treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta‐analysis;European Journal of Neurology;2023-05-29

5. Pathogenicity and virulence of Clostridioides difficile;Virulence;2023-01-04